These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


242 related items for PubMed ID: 37621941

  • 1. Psychedelics and neonihilism: connectedness in a meaningless world.
    Plesa P, Petranker R.
    Front Psychol; 2023; 14():1125780. PubMed ID: 37621941
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. LSD, madness and healing: Mystical experiences as possible link between psychosis model and therapy model.
    Wießner I, Falchi M, Palhano-Fontes F, Feilding A, Ribeiro S, Tófoli LF.
    Psychol Med; 2023 Mar; 53(4):1151-1165. PubMed ID: 34253268
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prescribing meaning: hedonistic perspectives on the therapeutic use of psychedelic-assisted meaning enhancement.
    Miceli McMillan R.
    J Med Ethics; 2021 Oct; 47(10):701-705. PubMed ID: 33148774
    [Abstract] [Full Text] [Related]

  • 6. Psychedelic Harm Reduction and Integration: A Transtheoretical Model for Clinical Practice.
    Gorman I, Nielson EM, Molinar A, Cassidy K, Sabbagh J.
    Front Psychol; 2021 Oct; 12():645246. PubMed ID: 33796055
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The Meaning-Enhancing Properties of Psychedelics and Their Mediator Role in Psychedelic Therapy, Spirituality, and Creativity.
    Hartogsohn I.
    Front Neurosci; 2018 Oct; 12():129. PubMed ID: 29559884
    [Abstract] [Full Text] [Related]

  • 11. The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world.
    Watts R, Kettner H, Geerts D, Gandy S, Kartner L, Mertens L, Timmermann C, Nour MM, Kaelen M, Nutt D, Carhart-Harris R, Roseman L.
    Psychopharmacology (Berl); 2022 Nov; 239(11):3461-3483. PubMed ID: 35939083
    [Abstract] [Full Text] [Related]

  • 12. Virtual Reality as a Moderator of Psychedelic-Assisted Psychotherapy.
    Sekula AD, Downey L, Puspanathan P.
    Front Psychol; 2022 Nov; 13():813746. PubMed ID: 35310225
    [Abstract] [Full Text] [Related]

  • 13. Psychedelics as Reemerging Treatments for Anxiety Disorders: Possibilities and Challenges in a Nascent Field.
    King F, Hammond R.
    Focus (Am Psychiatr Publ); 2021 Jun; 19(2):190-196. PubMed ID: 34690582
    [Abstract] [Full Text] [Related]

  • 14. Psychedelic-induced mystical experiences: An interdisciplinary discussion and critique.
    Mosurinjohn S, Roseman L, Girn M.
    Front Psychiatry; 2023 Jun; 14():1077311. PubMed ID: 37181886
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Psychosis and psychedelics: Historical entanglements and contemporary contrasts.
    Friesen P.
    Transcult Psychiatry; 2022 Oct; 59(5):592-609. PubMed ID: 36300247
    [Abstract] [Full Text] [Related]

  • 17. Psychedelics and Psychotherapy: Cognitive-Behavioral Approaches as Default.
    Yaden DB, Earp D, Graziosi M, Friedman-Wheeler D, Luoma JB, Johnson MW.
    Front Psychol; 2022 Oct; 13():873279. PubMed ID: 35677124
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ego-Dissolution and Psychedelics: Validation of the Ego-Dissolution Inventory (EDI).
    Nour MM, Evans L, Nutt D, Carhart-Harris RL.
    Front Hum Neurosci; 2016 Oct; 10():269. PubMed ID: 27378878
    [Abstract] [Full Text] [Related]

  • 20. Ethical and legal issues in psychedelic harm reduction and integration therapy.
    Pilecki B, Luoma JB, Bathje GJ, Rhea J, Narloch VF.
    Harm Reduct J; 2021 Apr 07; 18(1):40. PubMed ID: 33827588
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.